Standard

Лечение и профилактика фармакологическими препаратами синдрома ишемии-реперфузии при чрескожном коронарном вмешательстве. / Semigolovskiy, N.yu.; Lobachenko, I.g.; Simutis, I.s.; Danilov, M.s.; Yusupov, E.s.; Ratnikov, V.a.; Enkina, T.n.; Stelyukova, M.a.

в: КАРДИОЛОГИЯ И СЕРДЕЧНО-СОСУДИСТАЯ ХИРУРГИЯ, Том 18, № 2, 25.04.2025, стр. 191-200.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Semigolovskiy, NY, Lobachenko, IG, Simutis, IS, Danilov, MS, Yusupov, ES, Ratnikov, VA, Enkina, TN & Stelyukova, MA 2025, 'Лечение и профилактика фармакологическими препаратами синдрома ишемии-реперфузии при чрескожном коронарном вмешательстве', КАРДИОЛОГИЯ И СЕРДЕЧНО-СОСУДИСТАЯ ХИРУРГИЯ, Том. 18, № 2, стр. 191-200. https://doi.org/10.17116/kardio202518021191

APA

Semigolovskiy, N. Y., Lobachenko, I. G., Simutis, I. S., Danilov, M. S., Yusupov, E. S., Ratnikov, V. A., Enkina, T. N., & Stelyukova, M. A. (2025). Лечение и профилактика фармакологическими препаратами синдрома ишемии-реперфузии при чрескожном коронарном вмешательстве. КАРДИОЛОГИЯ И СЕРДЕЧНО-СОСУДИСТАЯ ХИРУРГИЯ, 18(2), 191-200. https://doi.org/10.17116/kardio202518021191

Vancouver

Semigolovskiy NY, Lobachenko IG, Simutis IS, Danilov MS, Yusupov ES, Ratnikov VA и пр. Лечение и профилактика фармакологическими препаратами синдрома ишемии-реперфузии при чрескожном коронарном вмешательстве. КАРДИОЛОГИЯ И СЕРДЕЧНО-СОСУДИСТАЯ ХИРУРГИЯ. 2025 Апр. 25;18(2):191-200. https://doi.org/10.17116/kardio202518021191

Author

Semigolovskiy, N.yu. ; Lobachenko, I.g. ; Simutis, I.s. ; Danilov, M.s. ; Yusupov, E.s. ; Ratnikov, V.a. ; Enkina, T.n. ; Stelyukova, M.a. / Лечение и профилактика фармакологическими препаратами синдрома ишемии-реперфузии при чрескожном коронарном вмешательстве. в: КАРДИОЛОГИЯ И СЕРДЕЧНО-СОСУДИСТАЯ ХИРУРГИЯ. 2025 ; Том 18, № 2. стр. 191-200.

BibTeX

@article{306def31c8224d4385458b4839ac2c73,
title = "Лечение и профилактика фармакологическими препаратами синдрома ишемии-реперфузии при чрескожном коронарном вмешательстве",
abstract = "Objective. To study modern strategies for pharmacological treatment and prevention of reperfusion-ischemia syndrome in percutaneous coronary intervention. Material and methods. Literature data were searched in the PubMed, Google Scholar and eLibrary databases.EN in accordance with PRISMA principles (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). Results. We found numerous strategies for treatment and prevention of reperfusion-ischemia syndrome in percutaneous coronary intervention. However, there is no a single technique ensuring absolute effectiveness. Various approaches, such as antioxidants, medications improving microcirculation and even innovative methods are actively being developed. However, their results can vary depending on characteristics of patients, degree of ischemia and other concomitant factors. Conclusion. The number of clinical studies devoted to cardiac protection during percutaneous coronary intervention significantly increased in recent years. This indicates high interest of medical community in the study of reperfusion-ischemia syndrome.",
keywords = "myocardial reperfusion-ischemia syndrome, percutaneous coronary intervention, prevention, succinate-containing preparations, treatment",
author = "N.yu. Semigolovskiy and I.g. Lobachenko and I.s. Simutis and M.s. Danilov and E.s. Yusupov and V.a. Ratnikov and T.n. Enkina and M.a. Stelyukova",
year = "2025",
month = apr,
day = "25",
doi = "10.17116/kardio202518021191",
language = "русский",
volume = "18",
pages = "191--200",
journal = "КАРДИОЛОГИЯ И СЕРДЕЧНО-СОСУДИСТАЯ ХИРУРГИЯ",
issn = "1996-6385",
publisher = "Медиа Сфера",
number = "2",

}

RIS

TY - JOUR

T1 - Лечение и профилактика фармакологическими препаратами синдрома ишемии-реперфузии при чрескожном коронарном вмешательстве

AU - Semigolovskiy, N.yu.

AU - Lobachenko, I.g.

AU - Simutis, I.s.

AU - Danilov, M.s.

AU - Yusupov, E.s.

AU - Ratnikov, V.a.

AU - Enkina, T.n.

AU - Stelyukova, M.a.

PY - 2025/4/25

Y1 - 2025/4/25

N2 - Objective. To study modern strategies for pharmacological treatment and prevention of reperfusion-ischemia syndrome in percutaneous coronary intervention. Material and methods. Literature data were searched in the PubMed, Google Scholar and eLibrary databases.EN in accordance with PRISMA principles (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). Results. We found numerous strategies for treatment and prevention of reperfusion-ischemia syndrome in percutaneous coronary intervention. However, there is no a single technique ensuring absolute effectiveness. Various approaches, such as antioxidants, medications improving microcirculation and even innovative methods are actively being developed. However, their results can vary depending on characteristics of patients, degree of ischemia and other concomitant factors. Conclusion. The number of clinical studies devoted to cardiac protection during percutaneous coronary intervention significantly increased in recent years. This indicates high interest of medical community in the study of reperfusion-ischemia syndrome.

AB - Objective. To study modern strategies for pharmacological treatment and prevention of reperfusion-ischemia syndrome in percutaneous coronary intervention. Material and methods. Literature data were searched in the PubMed, Google Scholar and eLibrary databases.EN in accordance with PRISMA principles (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). Results. We found numerous strategies for treatment and prevention of reperfusion-ischemia syndrome in percutaneous coronary intervention. However, there is no a single technique ensuring absolute effectiveness. Various approaches, such as antioxidants, medications improving microcirculation and even innovative methods are actively being developed. However, their results can vary depending on characteristics of patients, degree of ischemia and other concomitant factors. Conclusion. The number of clinical studies devoted to cardiac protection during percutaneous coronary intervention significantly increased in recent years. This indicates high interest of medical community in the study of reperfusion-ischemia syndrome.

KW - myocardial reperfusion-ischemia syndrome

KW - percutaneous coronary intervention

KW - prevention

KW - succinate-containing preparations

KW - treatment

UR - https://www.mendeley.com/catalogue/0517f580-5ea6-3f5d-8b92-70a4b16a0de8/

U2 - 10.17116/kardio202518021191

DO - 10.17116/kardio202518021191

M3 - статья

VL - 18

SP - 191

EP - 200

JO - КАРДИОЛОГИЯ И СЕРДЕЧНО-СОСУДИСТАЯ ХИРУРГИЯ

JF - КАРДИОЛОГИЯ И СЕРДЕЧНО-СОСУДИСТАЯ ХИРУРГИЯ

SN - 1996-6385

IS - 2

ER -

ID: 138031507